Agenus
AGEN
#9365
Rank
C$0.17 B
Marketcap
C$4.30
Share price
5.21%
Change (1 day)
-33.96%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): C$27.55 Million

According to Agenus 's latest financial reports the company's current earnings are C$0.10 Billion. In 2024 the company made an earning of -C$0.17 Billion, an increase over its 2023 earnings that were of -C$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$27.55 M-116.93%
2024 -C$0.17 Billion-28.13%
2023 -C$0.23 Billion-5.5%
2022 -C$0.24 Billion-556.26%
2021 C$52.51 M-130.37%
2020 -C$0.18 Billion73.75%
2019 -C$99.52 Million-48.74%
2018 -C$0.2 Billion34.32%
2017 -C$0.15 Billion-7.16%
2016 -C$0.16 Billion26.55%
2015 -C$0.13 Billion110.24%
2014 -C$58.52 Million49.12%
2013 -C$39.24 Million
2011 -C$27.1 Million-12.25%
2010 -C$30.88 Million-21.41%
2009 -C$39.29 Million-26.86%
2008 -C$53.72 Million13.72%
2007 -C$47.24 Million-33.4%
2006 -C$70.93 Million-31.84%
2005 -C$0.11 Billion9.74%
2004 -C$94.82 Million-0.8%
2003 -C$95.59 Million17.37%
2002 -C$81.44 Million37.83%
2001 -C$59.09 Million55.99%
2000 -C$37.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.87 B 125,627.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.66 B 63,550.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.62 B 46,345.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$14.21 B 48,350.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-C$0.41 Billion-1,490.73%๐Ÿ‡บ๐Ÿ‡ธ USA